Introduction
Parkinson's disease (PD) is a common aging-related neurodegenerative disease with progressive loss of dopaminergic neuron in the substantia nigra pars compacta (SNc) (Savitt et al., 2006; Ye et al., 2013; Kalia and Lang, 2015) . Although neuroinflammation, oxidative stress and mitochondrial dysfunction are believed to contribute to the damage of dopaminergic neurons, the precise pathological mechanism remain unknown (Dias et al., 2013; Camilleri and Vassallo, 2014; Menzies et al., 2015; Moon and Paek, 2015; Morris and Berk, 2015; Segura-Aguilar and Kostrzewa, 2015) . As a mitochondrial hydroxylase responsible for Coenzyme Q (ubiquinone) biosynthesis, Clk1 (coq7) plays an important role in electron transference in the mitochondrial respiratory chain (Nakai et al., 2001; Lapointe and Hekimi, 2008) . Clk1 +/-mutant mice exhibit a series of changes in mitochondrial metabolism such as reduced mitochondrial oxygen consumption, reduced electron transport and mitochondrial ATP synthesis (Hekimi, 2013) . Moreover, Clk1 deficiency induces apoptosis associated with mitochondrial dysfunction, which may lead to embryonic lethality in mice around E10.5 (Takahashi et al., 2008) . We reported recently that Clk1 deficiency sensitizes microglia-mediated neuroinflammation by altering metabolic reprogramming in microglial cells and subsequently increasing dopaminergic neuronal death induced by MPTP treatment, suggesting that Clk1 plays an important role in the survival of dopaminergic neurons via modulating microglia activation (Gu et al., 2017) . However, the direct functional role of Clk1 in dopaminergic neurons remains unknown.
This article has not been copyedited and formatted. The final version may differ from this version. The autophagy-lysosome pathway (ALP) is a critical cellular quality control system that involves degradation of dysfunctional cellular components and organelles.
Altered ALP is known to be associated with the pathological development of various neurodegenerative diseases including PD (Maiuri et al., 2007) . Enhancement of autophagy with over-expression of beclin1 effectively reduced the accumulation of α-synuclein and protected neurons in an animal model of PD (Spencer et al., 2009 ).
Furthermore, deletion of genes essential for autophagy, such as ATG7, resulted in PD-like neurodegeneration in mice (Komatsu et al., 2006) . Moreover, MPTP treatment leads to defective autophagosomal clearance due to impairment of lysosomal function in a model of PD (Dehay et al., 2010) . Therefore, ALP is essential for the survival of neuronal cells in response to an increased burden of misfolded protein or neurotoxicity (Decressac et al., 2013 ).
An in vivo study with CCI-779, a derivative of rapamycin, reduced the accumulation of α-synuclein by activation of autophagy, indicating that mTOR pathway plays a important role in the pathological development of neurodegenerative diseases (Ravikumar et al., 2004; Malagelada et al., 2006; Santini et al., 2009; Tain et al., 2009; Bar-Peled and Sabatini, 2014) . AMP-activated protein kinase (AMPK) is a upstream of target of rapamycin complex 1 (mTORC1), and activation of AMPK inhibits mTORC1 activity, thereby promoting autophagy (Choi et al., 2010) .
Furthermore, the AMPK activator metformin protects dopaminergic neurons in SNc in a mouse PD model via enhancement of AMPK-mediated autophagy, suggesting that the AMPK signaling pathway may constitute a potential target for PD therapy This article has not been copyedited and formatted. The final version may differ from this version. (Sardiello et al., 2009; Wu et al., 2011) . Recently, it has been shown that mTORC1 is a key regulator of the cellular localization and activity of transcription factor EB (TFEB) (Wong and Cuervo, 2010; Martina et al., 2012; Roczniak-Ferguson et al., 2012; Settembre et al., 2012; Martina and Puertollano, 2013) . TFEB is a major transcriptional regulator of the ALP pathway by regulating the expression of autophagic gene products such as ATG5, Beclin-1 and ATG9B, lysosomal gene products such as LAMP1, and cathepsins (Pena-Llopis et al., 2011; Settembre et al., 2011) . Altered TFEB function is involved in neurodegenerative diseases through regulating cargo recognition, autophagosome-lysosome fusion, and TFEB nuclear localization in ALP (Decressac et al., 2013; Chua et al., 2014; Cortes et al., 2014) .
The present study is designed to investigate the direct functional role of Clk1 in the regulation of dopaminergic neurons. We found that loss of Clk1 strongly increased MPTP neurotoxicity and inhibited autophagy through the AMPK/mTORC1 pathway.
Our data reveal a novel mechanism of Clk1-regulated dopaminergic neuronal survival.
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Plasmid and lentivirus (LV). EGFP-N3-tagged TFEB plasmid was provided by
Dr. Guanghui Wang. LV gene transfer vectors encoding shClk1 (LV2-shClk1, 5'-TGCCTTGTTGAAGAGGATTAT-3') and scrambled shRNA used as a negative control (LV2-NC, 5'-TTCTCCGAACGTGTCACGTTTC-3') were synthesized by GenePharma (Shanghai, China). The titer of lentivirus used was ≥ 3×10 8 units.
Polybrene was employed to promote the transduction of lentivirus and puromycin was applied to select successfully infected cells. After LV2-shClk1 was stably expressed, total RNA and proteins were extracted from MN9D cells to confirm the knockdown efficiency. For Clk1 over-expression assays and EGFP-TFEB assays, cells were This article has not been copyedited and formatted. The final version may differ from this version. After treatment with indicated drugs for 24 h, 30 μL of MTT solution (0.5 mg/mL) was added to each well. The plates were incubated at 37°C for 2 h in the dark. Then, after addition of 100 μL DMSO, the absorbance was read at 570 nm using a spectrophotometer.
Immunofluorescence. MN9D cells were washed with PBS and fixed with 4% paraformaldehyde for 15 min at room temperature. Then, the cells were incubated with blocking solution containing 3% BSA, 0.3% Triton-X 100 in PBS for 1 h, followed by incubation overnight at 4°C with primary antibodies anti-LC3 (1:500).
Subsequently, cells were washed 3 times with PBS and subjected to incubation with secondary fluorescent antibodies (1:400) for 2 h at room temperature. After 3 washes with PBS, samples were dyed with DAPI for 30 min at 37°C, followed by 3 more washes. Confocal microscopy (Carl Zeiss, Germany) was applied to the resultant images. were incubated overnight at 4°C with primary antibodies against, respectively: Clk1
Western blotting (WB
(1:1000), TH (1:1000), LC3 (1:3000), P62 (1:1000), LAMP1 (1:1000), p-AMPK
(1:1000), AMPK (1:1000), p-mTOR (1:1000), mTOR (1:1000), p-p70s6k (1:1000), p70s6k (1:1000) or internal reference antibodies Actin (1:10000). Then, the membranes were washed 3 times in TBST (TBS containing 0.1% Tween 20) and subjected to incubation with anti-rabbit or anti-mouse IgG polyclonal secondary antibodies (Sigma-Aldrich, USA). Following incubation with enhanced chemiluminescence (Millipore, USA), the band was determined with a ChemiScope 3300 Mini (CLINX, Shanghai, China). 
RNA isolation and real-time quantitative PCR (q-PCR

ADP/ATP Ratio Assay. ADP/ATP ratio was measured using an ADP/ATP Assay
This article has not been copyedited and formatted. The final version may differ from this version. buffer 95 μL, substrate 1 μL, co-subrate 1 μL and ATP enzyme 1 μL; 90 μL of ATP reagent was added to each well and the plate tapped briefly to mix. The plate was incubated for 1 min at room temperature. Luminescence activities were read and determined using a luminescence Reporter Assay System (Promega, USA) for the ATP assay (RLU A ). ADP reagent was prepared with 5 mL water and 1 μL ADP enzyme. After incubation for 10 min, luminescence was read as for ATP (RLU B ).
Immediately following the reading of RLU B , 5 mL ADP Reagent was added to each well and mixed by tapping the plate or pipetting. After 1 min, luminescence was read as above (RLU C ). ADP/ATP ratio was calculated using the formula ADP/ATP ratio = RLU C -RLU B / RLU A .
MPTP administration. MPTP-induced mouse model of PD was prepared according to our previously described procedures (Ren et al., 2016; Gu et al., 2017) were placed on the rotarod and the rotation speed increased from 5 to 40 rev/min during 5 min. Latency (time) to fall from the rotarod was automatically recorded.
Each mouse underwent three independent trials with a 20 min inter-trial interval, with latency to fall calculated as the average of the three trials (Ren et al., 2016) .
Pole test. Mice were placed head down on the top of a vertical wooden pole (60 cm in length, 2 cm in diameter) with a rough surface. Latency for the mice to climb down from the top of the pole to the base was measured. Trials were considered a failure if the mouse jumped or slid down the pole. Each mouse underwent three trials, with latency to climb down calculated as the average of the three trials (Ren et al., 2016) .
Immunohistochemistry. Following behavioral tests, animals were anesthetized with chloral hydrate (10%, i.p.) and brain tissue prepared as described previously. A freezing microtome was used to cut the midbrain into 20 μm serial sections containing the SNc for subsequent immunofluorescence staining. For staining, the midbrain sections were rinsed three times with 0.01 mol/L PBS and incubated in PBS containing 3% BSA and 0.3% Triton for 2 h at room temperature. The sections were washed in PBS and then incubated with anti-TH antibody (1:400) at 4°C for 24 h.
After washing with PBST (PBS containing 0.3% Triton), secondary fluorescent antibodies (1:400) were added for 2 h. The slides were then observed using a confocal microscope (Carl Zeiss, Germany).
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. (Gu et al., 2017) . To explore the direct effect of Clk1 on dopaminergic neuronal survival, MN9D cells were cultured with the indicated concentrations of MPP + for 24 h. As expected, MPP + produced neurotoxicity in MN9D cells (Fig. 1A) .
Interestingly, we detected a decrease in expression of Clk1 in MN9D cells treated with MPP + , suggesting that altered Clk1 expression may be involved in dopaminergic neuronal survival (Fig. 1B&C) . Knockdown of Clk1 with lentivirus expressing Clk1 Effective autophagic flux will lead to a decrease in its substrates, such as P62.
However, we found that expression of P62 was increased ( Fig. 2A) . This clearly indicated impairment in autophagy and lysosomal biogenesis in Clk1-deficient MN9D
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 2B ). In contrast, over-expression of Clk1 increased expression of LC3-II and LAMP1, whereas expression of P62 was decreased (Fig. 2C&D) . To further evaluate the autophagic flux (Klionsky et al., 2016) Clk1 regulates the AMPK/mTORC1 pathway. We reported previously that Clk1 regulated glycolytic metabolism in microglia cells (Gu et al., 2017) . As the ADP/ATP ratio is an important index of cellular energy status that directly affects activity of AMPK (Hardie, 2007) , we examined the effect of Clk1 on the ADP/ATP This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 3A) . It is known that mTORC1 activation plays an important role in the regulation of autophagy, while AMPK phosphorylation negatively regulates mTOR activation (Puente et al., 2016) . We found that Clk1 knockdown enhanced phosphorylation of mTOR on Serine 2448 (S2448) and the mTOR substrate p70s6k
on Threonine 389 (T389) in MN9D cells (Fig. 3B) . These results indicated that Clk1 is involved in the regulation of the AMPK/mTORC1 signaling pathway in MN9D cells. Furthermore, metformin prevented the effect of Clk deficiency to sensitize MN9D cell death in response to MPP + (Fig. 4C) . Collectively, these results clearly showed that
Clk1 mediates autophagy through
Clk1 inhibited autophagy through the AMPK/mTORC1 signaling pathway and that
This article has not been copyedited and formatted. The final version may differ from this version. Clk1 regulates the nuclear translocation of TFEB. TFEB, which is regulated by mTORC1 (Wong & Cuervo, 2010; Pena-Llopis et al., 2011; Settembre et al., 2011; Decressac et al., 2013; Chua et al., 2014) , is a transcription factor involved in autophagy and is functionally associated with neurodegenerative disease (Settembre et al., 2012; Martina and Puertollano, 2013) . We therefore considered whether Clk1 is able to regulate TFEB. Nuclear translocation of TFEB was decreased by Clk1 knockdown after starvation in MN9D cells (Fig. 5A) , while over-expression of Clk1 led to increased nuclear translocation of TFEB (Fig. 5B) . Moreover, metformin increased nuclear translocation of TFEB in Clk1-deficient MN9D cells (Fig. 5C ).
These findings indicate that Clk1 regulates the nuclear translocation of TFEB. To further confirm this observation, we next assessed the expression levels of lysosomal and autophagic genes in Clk1-deficient cells. Clk1-deficient cells indeed resulted in a global decrease in mRNA expression levels of a set of TFEB target genes, including genes involved in lysosomal biogenesis and function, such as LAMP1, genes encoding subunits of vacuolar ATPases and cathepsins, and genes involved in autophagy (ATG5 and ATG9B; Fig. 5D ). given in Fig. 8A . As expected, MPTP-treated Clk +/-mice showed enhanced behavioral impairment as compared to wild type mice. Pretreatment with metformin attenuated the behavioral impairments induced by MPTP treatment (Fig. 8B&C) . Furthermore, metformin pretreatment attenuated the decrease in number of TH-positive neurons in SNc, as indicated by immunostaining or TH protein levels by western blot, in mice treated with MPTP (Fig. 8D ). In agreement with the data observed in MN9D cells, LC3-II expression was up-regulated and P62 expression was down-regulated in SNc of Clk-deficient MPTP-treated mice pretreated with metformin (Fig. 8E) . Taken together, the present data indicate that metformin enhanced autophagy and ameliorated MPTP neurotoxicity on dopaminergic neurons in Clk +/-mice.
Clk1 mutant mice exhibit the impaired autophagy in striatum and
This article has not been copyedited and formatted. The final version may differ from this version. pathway, which in turn impaired the autophagy-lysosome pathway and TFEB nuclear translocation, and consequentially promoted dopaminergic neuronal damage in vivo and in vitro; this ultimately contributed to sensitization to MPTP-induced dopaminergic neuronal death and behavioral impairments in Clk1-deficient mice.
Moreover, we found that activation of autophagy by metformin treatment increased dopaminergic neuronal survival in vitro and in the MPTP model of PD. These results reveal that Clk1 plays an important role in dopaminergic neuronal survival via regulation of ALP pathways that may contribute to the pathological development of PD. Thus, modulation of Clk1 activity may represent a potential therapeutic target for PD.
Clk1 (coq7) is essential for electron transference in the mitochondrial respiratory chain (Nakai et al., 2001; Lapointe and Hekimi, 2008) . Deficiency in Clk1 function is known to alter mitochondrial metabolism, including reduced mitochondrial oxygen consumption, impaired electron transport and mitochondrial ATP synthesis (Hekimi, 2013) . Our previous study found that loss of Clk1 in microglia promotes neuroinflammation through regulation of microglial metabolic reprogramming and, This article has not been copyedited and formatted. The final version may differ from this version. consequently, enhances dopaminergic neuronal death (Gu et al., 2017) . However, a direct role of Clk1 in the regulation of dopaminergic neuronal survival has not been explored. In the present study, we found that silencing Clk1 sensitized MPP + -induced neurotoxcity toward dopaminergic neurons in cultured MN9D dopaminergic cells.
These findings indicate that Clk1 is indeed involved in the regulation of dopaminergic neuronal survival. To explore the underlying mechanism, we found that silencing Clk1 inhibited autophagy in MN9D cells, as evidenced by down-regulation of LC3-II and LAMP1 in MN9D cells and in SNc of Clk +/-mice (Fig. 6A&B) . Importantly, activation of autophagy by metformin treatment protected dopaminergic neurons from the neurotoxic effects of MPTP administration in both Clk1-deficient and in MPTP-treated wild type animal (Fig. 8B&C) . Although it has been reported that inhibition of autophagy favors cell survival (Feng et al., 2014) , here we showed that Clk1 deficiency resulted in impairment of autophagy that sensitized cells to MPTP-induced neurotoxicity. In agreement with other reports (Lee et al., 2015; Hwang et al., 2016) , our data indicate that induction of autophagy is protective on cell survival in our system. Although a role for the ALP pathway in the development of PD may appear complex, it may be explained by following points: (1) In the early stage of PD, when the lysosome is not severely impaired, enhancement of autophagy may be a complementary response to sustain normal functions by degrading dysfunctional cellular components and organelles, hence, the ALP pathway could play differing roles according to the stage of PD development; (2) We found that Clk1 deficiency inhibited autophagy under basal conditions and in MPP + -treated neurons.
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The serine/threonine kinase mTOR regulates cell survival and proliferation and is also known to be a major negative regulator of autophagy. Upstream of mTORC1, AMPK is a metabolic sensor, such that activation of AMPK protects neuronal survival through regulating mitochondrial biogenesis and maintaining energy balance (Egan et al., 2011) . Activation of AMPK inhibits mTOR and induces autophagy (Li et al., 2013; Guo et al., 2014 ). As we have previously shown that Clk1 modulates AMPK activity and energy metabolism in microglia cells, we therefore investigated the role of the AMPK/mTORC1 signaling pathway in inhibition of autophagy by Clk1 deficiency in dopaminergic neurons. We found knockdown of Clk1 in MN9D dopaminergic neurons resulted in suppression of AMPK activation and elevation of phosphorylation of mTOR and the mTOR substrate p70s6k (Fig. 3B) . Furthermore, we found that Clk1 regulated transcription factor TFEB nuclear translocation and TFEB-targeted genes, which was dependent on the AMPK/mTORC1 signaling pathway. Mechanistic studies demonstrated that Clk1 regulated TFEB nuclear translocation through the AMPK/mTORC1 signaling pathway.
Our previous study has demonstrated that increased dopaminergic neuronal loss may be associated with enhanced microglia activation in Clk1 +/-mice treated with MPTP, (Gu et al., 2017) . The present study provides evidences that Clk1 is directly involved in the regulation of dopaminergic neuronal survival. This appears to be mediated via changes in autophagy consequent to alterations in the AMPK/mTORC1
pathway. Indeed, pretreatment with metformin ameliorated MPTP-induced behavioral This article has not been copyedited and formatted. The final version may differ from this version. Fig. 8B-D) . The underlying mechanism may be attributed to enhanced autophagy by AMPK/mTORC1 in dopaminergic neurons. Our data thus indicates that, in addition to modulating microglia-mediated inflammation, Clk1 exerts neuroprotection by directly regulating autophagic activity of dopaminergic cells.
In conclusion, we found that Clk1 is directly involved in the regulation of dopaminergic neuronal survival by mediating autophagy via the AMPK/mTORC1
pathway. Modulation of Clk1 activity may represent a potential novel therapeutic approach for PD.
This article has not been copyedited and formatted. The final version may differ from this version. MN9D cells were transfected as in (A), followed by immunofluorescence assay using antibody against LC3 (green). DAPI (blue) was used for nuclear staining. Cells were visualized using confocal microscopy (scale bar 5 μm), with quantification of LC3
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Fig. 6 Striatum and SNc of Clk1 mutant mice exhibit impaired autophagy. (A, B)
Wild type (WT) and Clk1 +/-mouse striatum and SNc were dissected and processed as described in Methods. Protein levels of LC3, P62, LAMP1, TH and Clk1 were determined by Western blot analysis. n=4 mice per group. *P<0.0167, **P<0.01, ***P<0.001 vs wild type. +/-mouse striatum and SNc were dissected and processed as described in Methods.
Protein levels of p-AMPK, p-mTOR, p-p70s6k and Clk1 were determined by Western blot analysis. n=4 mice per group. *P<0.0167 and ** P<0.01 vs wild type.
